Literature DB >> 29042492

Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke.

Vera Zietemann1, Anna Kopczak1, Claudia Müller1, Frank Arne Wollenweber1, Martin Dichgans2.   

Abstract

BACKGROUND AND
PURPOSE: Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, evidence to define optimal cut-offs for mild cognitive impairment (MCI) after stroke is limited.
METHODS: We studied 105 patients enrolled in the prospective DEDEMAS study (Determinants of Dementia After Stroke; NCT01334749). Follow-up visits at 6, 12, 36, and 60 months included comprehensive neuropsychological testing and the Clinical Dementia Rating scale, both of which served as reference standards. The original TICS and T-MoCA were obtained in 2 separate telephone interviews each separated from the personal visits by 1 week (1 before and 1 after the visit) with the order of interviews (TICS versus T-MoCA) alternating between subjects. Area under the receiver-operating characteristic curves was determined.
RESULTS: Ninety-six patients completed both the face-to-face visits and the 2 interviews. Area under the receiver-operating characteristic curves ranged between 0.76 and 0.83 for TICS and between 0.73 and 0.94 for T-MoCA depending on MCI definition. For multidomain MCI defined by multiple-tests definition derived from comprehensive neuropsychological testing optimal sensitivities and specificities were achieved at cut-offs <36 (TICS) and <18 (T-MoCA). Validity was lower using single-test definition, and cut-offs were higher compared with multiple-test definitions. Using Clinical Dementia Rating as the reference, optimal cut-offs for MCI were <36 (TICS) and approximately 19 (T-MoCA).
CONCLUSIONS: Both the TICS and T-MoCA are valid screening tools poststroke, particularly for multidomain MCI using multiple-test definition.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  ROC curve; Telephone Interview of Cognitive Status; Telephone Montreal Cognitive Assessment; mild cognitive impairment; stroke; validation

Mesh:

Year:  2017        PMID: 29042492     DOI: 10.1161/STROKEAHA.117.017519

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.

Authors:  Terence J Quinn; Edo Richard; Yvonne Teuschl; Thomas Gattringer; Melanie Hafdi; John T O'Brien; Niamh Merriman; Celine Gillebert; Hanne Huyglier; Ana Verdelho; Reinhold Schmidt; Emma Ghaziani; Hysse Forchammer; Sarah T Pendlebury; Rose Bruffaerts; Milija Mijajlovic; Bogna A Drozdowska; Emily Ball; Hugh S Markus
Journal:  Eur Stroke J       Date:  2021-10-08

Review 2.  Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia.

Authors:  Lucy C Beishon; Emma Elliott; Tuuli M Hietamies; Riona Mc Ardle; Aoife O'Mahony; Amy R Elliott; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2022-04-08

3.  Intraoperative Oxygen Concentration and Neurocognition after Cardiac Surgery.

Authors:  Shahzad Shaefi; Puja Shankar; Ariel L Mueller; Brian P O'Gara; Kyle Spear; Kamal R Khabbaz; Aranya Bagchi; Louis M Chu; Valerie Banner-Goodspeed; David E Leaf; Daniel S Talmor; Edward R Marcantonio; Balachundhar Subramaniam
Journal:  Anesthesiology       Date:  2021-02-01       Impact factor: 7.892

4.  T-MoCA: A valid phone screen for cognitive impairment in diverse community samples.

Authors:  Mindy J Katz; Cuiling Wang; Caroline O Nester; Carol A Derby; Molly E Zimmerman; Richard B Lipton; Martin J Sliwinski; Laura A Rabin
Journal:  Alzheimers Dement (Amst)       Date:  2021-02-05

5.  Feasibility of remote neurocognitive assessment: pandemic adaptations for a clinical trial, the Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy (COPE-PAP) study.

Authors:  Annie C Lajoie; Joelle Crane; Ann R Robinson; Anne-Louise Lafontaine; Andrea Benedetti; R John Kimoff; Marta Kaminska
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

6.  A pilot study of trained ICU doulas providing early psychological support to critically ill patients.

Authors:  Lioudmila V Karnatovskaia; Katalin Varga; Alexander S Niven; Phillip J Schulte; Midhat Mujic; Ognjen Gajic; Brent A Bauer; Matthew M Clark; Roberto P Benzo; Kemuel L Philbrick
Journal:  Crit Care       Date:  2021-12-20       Impact factor: 19.334

7.  Utility of a short, telephone-administered version of the Montreal Cognitive Assessment.

Authors:  Lee A Jennings; Katy L B Araujo; Can Meng; Peter Peduzzi; Peter Charpentier; David B Reuben
Journal:  J Am Geriatr Soc       Date:  2021-06-17       Impact factor: 7.538

8.  Apathy and actions- another consideration when theorizing about embodied nature of language in Parkinson's disease.

Authors:  Logan Wolff; Jared F Benge; Samia Ortiz-Hernandez; Samantha Beevers; Alexandra Armitage; Jungjun Park; Daniel L Drane
Journal:  J Commun Disord       Date:  2021-07-28       Impact factor: 1.864

Review 9.  Cognitive Assessment via Telephone: A Scoping Review of Instruments.

Authors:  Anne R Carlew; Hudaisa Fatima; Julia R Livingstone; Caitlin Reese; Laura Lacritz; Cody Pendergrass; Kenneth Chase Bailey; Chase Presley; Ben Mokhtari; Colin Munro Cullum
Journal:  Arch Clin Neuropsychol       Date:  2020-11-19       Impact factor: 2.813

10.  PRediction of acute coronary syndrome in acute ischemic StrokE (PRAISE) - protocol of a prospective, multicenter trial with central reading and predefined endpoints.

Authors:  Christian H Nolte; Regina von Rennenberg; Simon Litmeier; Jan F Scheitz; David M Leistner; Stephan Blankenberg; Martin Dichgans; Hugo Katus; Gabor C Petzold; Burkert Pieske; Vera Regitz-Zagrosek; Karl Wegscheider; Andreas M Zeiher; Ulf Landmesser; Matthias Endres
Journal:  BMC Neurol       Date:  2020-08-27       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.